Apply now! Call for Mentors: One Health Early Career Champions
We invite you to join the One Health Early Career Champions (ECC) Program as a mentor to support talented doctoral researchers from Kenya and Finland. This program unites accomplished early career researchers and academics from the University of Nairobi and the University of Helsinki.
Apply now! Call for Mentees: One Health Early Career Champions
The One Health Early Career Champions–program (ECC) offers you the opportunity to become a part of the ECC community at the universities of Nairobi and Helsinki. As a mentee in the program, you will benefit from the personal career advice and guidance of two carefully chosen mentors and one experienced researcher from each university. This opportunity is open to a maximum of twelve doctoral researchers, six from Nairobi and six from Helsinki.
The University held a public forum on COVID-19 on Thursday 12th March 2020 at the Chandaria Auditorium, UoN Towers.
The forum brought together staff, students and members of the public to discuss the impact of COVID-19 and potential solutions.
On 10th January 2020, we hosted a delegation of students and teachers from Linnankoski High school and Linnajoki secondary school in Porvoo, Finland. The delegation was an educational tour; with a focus on the effects of climate change and health.
We are pleased to announce the first Institut Mérieux – KAVI-Institute of Clinical Research Young Investigator Award Winner, Dr Loice Achieng.
The New Year started on 24th January 2020 for KAVI-ICR Journal club with Professor Jason Kindrachuk from the Department of Medical Microbiology & Infectious Diseases, University of Manitoba, Presenting on Ebola Virus. The presentation was titled 'Identifying the molecular determinants underlying Ebola virus persistence in incidental and reservoir hosts.' The KAVI-ICR Journal club brings together scientists and students twice a month to listen to presentations of various projects.
World AIDs Day is a global event marked on the 1st of December each year. The occasion is held in support of People Living with HIV/AIDs, to commemorate those who have passed on due to HIV/AIDs related causes as well as celebrating the success and advancements made in the last decades in the prevention/management of HIV.
Newly emerging pathogens including bacterial pathogens with emerging resistance to current antimicrobial agents pose a major public health problem globally. There is an urgent need for more trans-disciplinary and trans-sectorial approaches to prioritize and tackle this emerging public health problem.
On 24th September 2019, the first volunteer was enrolled in the IAVI-W001 study at the KAVI-Institute of Clinical Research (KAVI-ICR) of the University of Nairobi. The occasion marks the beginning of the 12th HIV vaccine clinical trial to be conducted at KAVI-ICR since 2001. This is a first-in-human study that uses a Native-trimer HIV envelope design that will hopefully stimulate broadly neutralizing antibodies against HIV.
